CHRN ChronoScale Holdings Corp
General Industrial Machinery & Equipment, NEC · Nasdaq · SEC CIK 1549084 · Fiscal year ends 05/31
Financial factors as of 2025-06-30 (2025Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-19.3%
TTM net income YoY10.8%
TTM EPS YoY-21.2%
Revenue 3-yr CAGR4.0%
Net income 3-yr CAGR—
Margins
Gross margin51.5%
Operating margin-83.8%
Net margin-75.7%
FCF margin-62.8%
EBITDA margin-73.2%
Returns
ROE-96.4%
ROA-44.2%
ROIC (approx.)-163.6%
Asset turnover0.58x
Leverage & solvency
Liabilities / assets52.8%
Debt / equity0.00x
Current ratio2.38x
Interest coverage-44.67x
Cash quality & payout
Operating cash flow / net income0.82x
Accruals ratio-7.8%
Payout ratio—
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-05-31 | FY20252025-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $71.60M | $12.80M |
| Cost of revenue | $88.69M | $5.95M |
| Gross profit | -$17.09M | $6.84M |
| R&D expense | — | $3.03M |
| SG&A expense | $19.81M | $9.99M |
| Operating income | -$37.50M | -$13.33M |
| Interest expense | — | $309,000 |
| Pretax income | -$49.30M | -$11.70M |
| Income tax | $0 | $0 |
| Net income | -$50.32M | -$11.70M |
| EBITDA | $22.84M | -$11.75M |
| EPS (basic) | -0.36 | -4.91 |
| EPS (diluted) | -0.36 | -4.91 |
| Weighted avg. shares (diluted) | 138.70M | — |
| Balance sheet | ||
| Cash & equivalents | $9.66M | $1.17M |
| Receivables | $12.54M | $7.31M |
| Inventory | — | $4.82M |
| Current assets | $44.25M | $14.05M |
| PP&E, net | $32.08M | $1.29M |
| Goodwill | $54.51M | $431,000 |
| Intangibles | — | $3.50M |
| Total assets | $325.87M | $20.11M |
| Current liabilities | $86.89M | $8.64M |
| Short-term debt | $3.37M | — |
| Long-term debt | $474,000 | — |
| Total debt | $3.84M | — |
| Total liabilities | $143.84M | $11.08M |
| Shareholders' equity | $180.03M | $9.03M |
| Net debt | -$5.82M | — |
| Shares outstanding | 145.21M | 3.56M |
| Cash flow statement | ||
| Operating cash flow | $39.07M | -$11.80M |
| Capital expenditure | $26.88M | $188,000 |
| Free cash flow | $12.19M | -$11.99M |
| Investing cash flow | -$25.17M | -$188,000 |
| Financing cash flow | -$6.63M | $6.63M |
| Depreciation & amortization | $60.34M | $1.57M |
| Stock-based compensation | $1.30M | $1.47M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.